Science Angel Syndicate

Type

Angel Group/Syndicate

Status

Active

Location

Bristol, United Kingdom

Total investments

11

Average round size

1M

Portfolio companies

10

Rounds per year

3.67

Follow on index

0.09

Areas of investment
BiotechnologyHealth DiagnosticsRoboticsMedicalTherapeuticsSustainabilityWaste ManagementIndustrial AutomationEnvironmental ConsultingChemical Engineering

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
11
Lead investments
0
Rounds per year
3.67
Follow on index
0.09
Investments by industry
  • Biotechnology (5)
  • Medical (3)
  • Therapeutics (2)
  • Sustainability (1)
  • Environmental Consulting (1)
  • Show 21 more
Investments by region
  • United Kingdom (11)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
178K
Group Appearance index
0.91

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
WASE 24 Mar 2022 Sustainability, Waste Management, Environmental Consulting Seed 959K England, London, United Kingdom
Zentraxa 27 May 2023 Biotechnology, Test and Measurement Seed England, Bristol, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.